ADVERSE DRUG EVENT REPORTING OF REMDESIVIR
Author(s):
Gawali Vijay Appu, Dipak A. Joshi, Shyamlila B. Bavage, Nandkishor B. Bavage
Keywords:
Abstract
Purpose; Remdesivir shows promise in the treatment of COVID19 patients. Despite this, it is still necessary to record potential drug side effects (PBL) for future decision-making. Same as the limited ADE data available before the COVID19 pandemic.
Article Details
Unique Paper ID: 152387

Publication Volume & Issue: Volume 8, Issue 3

Page(s): 159 - 161
Article Preview & Download


Share This Article

Conference Alert

ICM - STEP

International conference on Management, Science, Technology, Engineering, Pharmact and Humanities.

Go To Issue



Call For Paper

Volume 8 Issue 4

Last Date 25 September 2021

About Us

IJIRT.org enables door in research by providing high quality research articles in open access market.

Send us any query related to your research on editor@ijirt.org

Social Media

Google Verified Reviews

Contact Details

Telephone:6351679790
Email: editor@ijirt.org
Website: ijirt.org

Policies